Muscle and Tendon Regeneration Will Revolutionize Sports Medicine

By Ray Dirks   
Thursday, 16 October 2014 15:40
This trade thesis is being presented to premium subscriber only.
Read more...
 

What's Next: Investors Place Ebola Pandemic Stock Bets

By M.E.Garza   
Monday, 06 October 2014 15:22

This trade thesis  is being presented to premium subscribers only.

Read more...
 

Bottom bouncer with quick trade profit potential

By David Ibrahim   
Friday, 03 October 2014 07:31

This trade idea is being presented to premium subscribers only.

Read more...
 

Phase IIb Study Results Expected this Quarter

By M.E.Garza   
Tuesday, 30 September 2014 07:27
icon_tradethesisThis trade idea is being posted for premium subscribers first.
Read more...
 

Promising with interim data coming, but should you buy?

By William Kent   
Thursday, 25 September 2014 13:37
Prostate cancer is the most common cancer among men in the United States.
Read more...
 

Are You Buying or Selling This Biotech?

By Staff and Wire Reports   
Tuesday, 19 August 2014 02:11

icon_closerlookThis report is being released for our premium subscribers first.

Read more...
 

What To Buy While Biotechs Get Crushed

By Brian Wilson   
Wednesday, 16 July 2014 12:09

This report contains content that is for premium subscribers only

Read more...
 

This PDUFA Play Looks Enticing

By Brian Wilson   
Friday, 11 July 2014 08:54

This report contains content that is for premium subscribers only.

Read more...
 

Keep An Eye On This Volatile Rare Disease Stock

By Brian Wilson   
Tuesday, 08 July 2014 09:05

This report contains content that is for premium subscribers only.

 

 

Read more...
 

Will This Biotech Recover Lost Ground?

By Brian Wilson   
Tuesday, 01 July 2014 09:14

This report contains content that is for premium subscribers only.

Read more...
 
<< Start < Prev 1 3 4 5 6 7 8 9 10 > End >>

Page 1 of 56

Newsletter

BioMedReports CytRx Announces Publication of Phase 1b/2 Aldoxorubicin; NewLink Genetics Announces Licensing Agreement For De... http://t.co/l9LvyQgryr
5hreplyretweetfavorite
BioMedReports Active Stocks: Advaxis, DexCom, Cytokinetics, Valeant Pharmaceuticals, New Link Genetics: U.S. stocks moved mo... http://t.co/Zhnt4Dj44W
11hreplyretweetfavorite
BioMedReports Merrill Lynch’s 5 Destroyed Biotech Stocks With 100% or More Upside Potential... http://t.co/p5To7JFYL2
18hreplyretweetfavorite
navigation
Benzinga.com supporter Seeking Alpha Certified